These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 25734941)

  • 21. Cardiac resynchronization therapy in patients with heart failure and moderately reduced ejection fraction: Could it trigger a super-response?
    Tawfik Ghanem M; Allam LE; Samir Ahmed R
    Indian Heart J; 2019; 71(3):229-234. PubMed ID: 31543195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Answer. Reverse remodeling in systolic heart failure. The ST2-R2 score: a puzzle yet to be solved?
    Lupón J; Bayes-Genis A
    Int J Cardiol; 2015 May; 187():556. PubMed ID: 25880401
    [No Abstract]   [Full Text] [Related]  

  • 24. N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure.
    Zelt JGE; Liu PP; Erthal F; deKemp RA; Wells G; O'Meara E; Garrard L; Beanlands RSB; Mielniczuk LM
    Can J Cardiol; 2017 Nov; 33(11):1478-1488. PubMed ID: 28966019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure.
    Gaggin HK; Szymonifka J; Bhardwaj A; Belcher A; De Berardinis B; Motiwala S; Wang TJ; Januzzi JL
    JACC Heart Fail; 2014 Feb; 2(1):65-72. PubMed ID: 24622120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
    Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
    Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of multiple biomarkers for mortality prediction in patients with acute heart failure of ischemic and nonischemic etiology.
    Zhang M; Meng Q; Qi X; Han Q; Qi X; Wang F; Du B
    Biomark Med; 2018 Nov; 12(11):1207-1217. PubMed ID: 30499308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of left ventricular reverse remodeling and brain natriuretic peptide level at one year after cardiac resynchronization therapy predicts long-term clinical outcome.
    Roubicek T; Stros J; Kucera P; Nedbal P; Cerny J; Polasek R; Wichterle D
    PLoS One; 2019; 14(7):e0219966. PubMed ID: 31314790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarker-based risk prediction in the community.
    AbouEzzeddine OF; McKie PM; Scott CG; Rodeheffer RJ; Chen HH; Michael Felker G; Jaffe AS; Burnett JC; Redfield MM
    Eur J Heart Fail; 2016 Nov; 18(11):1342-1350. PubMed ID: 27813304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes.
    Felker GM; Fiuzat M; Thompson V; Shaw LK; Neely ML; Adams KF; Whellan DJ; Donahue MP; Ahmad T; Kitzman DW; Piña IL; Zannad F; Kraus WE; O'Connor CM
    Circ Heart Fail; 2013 Nov; 6(6):1172-9. PubMed ID: 24103327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.
    Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y
    Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction.
    Moliner P; Lupón J; Barallat J; de Antonio M; Domingo M; Núñez J; Zamora E; Galán A; Santesmases J; Pastor C; Bayes-Genis A
    Int J Cardiol; 2018 Apr; 257():188-192. PubMed ID: 29415801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trajectories of Left Ventricular Ejection Fraction After Acute Decompensation for Systolic Heart Failure: Concomitant Echocardiographic and Systemic Changes, Predictors, and Impact on Clinical Outcomes.
    Albert J; Lezius S; Störk S; Morbach C; Güder G; Frantz S; Wegscheider K; Ertl G; Angermann CE
    J Am Heart Assoc; 2021 Feb; 10(3):e017822. PubMed ID: 33496189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Biomarkers of Cardiac Stress, Cardiovascular Dysfunction, and Outcomes in HIV-Infected Individuals.
    Secemsky EA; Scherzer R; Nitta E; Wu AH; Lange DC; Deeks SG; Martin JN; Snider J; Ganz P; Hsue PY
    JACC Heart Fail; 2015 Aug; 3(8):591-9. PubMed ID: 26164679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure?
    Fudim M; Kelly JP; Jones AD; AbouEzzeddine OF; Ambrosy AP; Greene SJ; Reddy YNV; Anstrom KJ; Alhanti B; Lewis GD; Hernandez AF; Felker GM
    Am Heart J; 2020 Feb; 220():97-107. PubMed ID: 31805424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ST2 and left ventricular remodeling after ST-segment elevation myocardial infarction: A cardiac magnetic resonance study.
    Miñana G; Núñez J; Bayés-Genís A; Revuelta-López E; Ríos-Navarro C; Núñez E; Chorro FJ; López-Lereu MP; Monmeneu JV; Lupón J; Bodí V
    Int J Cardiol; 2018 Nov; 270():336-342. PubMed ID: 29954670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure.
    Bayes-Genis A; Pascual-Figal D; Januzzi JL; Maisel A; Casas T; Valdés Chávarri M; Ordóñez-Llanos J
    Rev Esp Cardiol; 2010 Oct; 63(10):1171-8. PubMed ID: 20875357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left atrial rather than left ventricular impaired mechanics are associated with the pro-fibrotic ST2 marker and outcomes in heart failure with preserved ejection fraction.
    Nagy AI; Hage C; Merkely B; Donal E; Daubert JC; Linde C; Lund LH; Manouras A
    J Intern Med; 2018 Apr; 283(4):380-391. PubMed ID: 29430747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure.
    Ky B; French B; McCloskey K; Rame JE; McIntosh E; Shahi P; Dries DL; Tang WH; Wu AH; Fang JC; Boxer R; Sweitzer NK; Levy WC; Goldberg LR; Jessup M; Cappola TP
    Circ Heart Fail; 2011 Mar; 4(2):180-7. PubMed ID: 21178018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.